Literature DB >> 15362057

Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question.

G Ramadori, B Saile.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15362057     DOI： 10.1053/j.gastro.2004.07.041

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  28 in total

Review 1.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

Review 2.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 3.  Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

Authors:  Alex Boye; Yu-Hong Zou; Yan Yang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.

Authors:  Memy H Hassan; Mohamed M Ghobara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-31       Impact factor: 3.000

5.  Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.

Authors:  Bassem Refaat; Ahmed Mohammed Ashshi; Adel Galal El-Shemi; Adnan AlZanbagi
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

6.  Anti-inflammatory effect of insulin in the human hepatoma cell line HepG2 involves decreased transcription of IL-6 target genes and nuclear exclusion of FOXO1.

Authors:  Emelie Wallerstedt; Madeléne Sandqvist; Ulf Smith; Christian X Andersson
Journal:  Mol Cell Biochem       Date:  2011-02-05       Impact factor: 3.396

Review 7.  Deciphering the complexity of acute inflammation using mathematical models.

Authors:  Yoram Vodovotz
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 8.  Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.

Authors:  Tamara Severi; Hannah van Malenstein; Chris Verslype; Jos F van Pelt
Journal:  Acta Pharmacol Sin       Date:  2010-10-18       Impact factor: 6.150

9.  Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis.

Authors:  Haralabos C Karantonis; Georgios Gribilas; Ioannis Stamoulis; Constantinos Giaginis; Chara Spiliopoulou; Gregorios Kouraklis; Constantinos Demopoulos; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

Review 10.  Cytokines and HCV-related disorders.

Authors:  Poupak Fallahi; Clodoveo Ferri; Silvia Martina Ferrari; Alda Corrado; Domenico Sansonno; Alessandro Antonelli
Journal:  Clin Dev Immunol       Date:  2012-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.